ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a Monotherapy and in Combination with Chemotherapy and the PARP Inhibitor Olaparib.
Cancer Res. 2022 Mar 15;82(6):1140-1152. doi: 10.1158/0008-5472.CAN-21-2997.
Cancer Res. 2022.
PMID: 35078817